About: Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1996 (uk) im Oktober 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1996 (ast) scientific article published on 01 October 1996 (en)
publication date	wds:Q71590582-E178EC94-3FC9-4918-A267-AC555ED5DC69
publication date	1996-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71590582-33560872-37CF-4AA4-8FC3-A73FE39D60B6
language of work or name	English
cites work	wds:Q71590582-0FCED73F-D80A-4DAF-9AA5-618194B65559 wds:Q71590582-2A1FCDF5-2452-4E2C-B8F6-BC509C214CF5 wds:Q71590582-342AC655-478F-4007-A456-6C6694D6068B wds:Q71590582-7256B066-3A15-42F4-BD93-25D179F79F4F wds:Q71590582-9FC1C22B-FF29-4551-A671-E740111046FF wds:Q71590582-A7E72426-F966-4420-B1DA-2D8AE59491BD wds:Q71590582-B2BAF34D-5F54-4B74-8EE7-1B9F104A18EE
cites work	Epidemiology of heart failure Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine. The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure Short-term use of intravenous milrinone for heart failure Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure
author name string	wds:Q71590582-026CEF74-97CF-4653-A7BF-E9933A9609FA wds:Q71590582-2B70BA5D-BC94-4BD7-AC66-512AE4F7BE42 wds:Q71590582-36FCD4CF-18AC-475A-A470-B0B44E060F68 wds:Q71590582-932B12C2-50A3-4A18-87B1-4A4231485E5D wds:Q71590582-AE349385-6136-47CA-9D3D-6601C0CCF99A wds:Q71590582-E9B4980C-18DF-4975-A06B-FADEBC2F57DE wds:Q71590582-F6717EFD-D63A-472D-8AD3-C5950BEB9C47
author name string	E Silber W A Clark P Denes R N Fernandez L Heaney A L Marius-Nunez A Ranganini
rdfs:label	Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure (en) Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure (nl)
skos:prefLabel	Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure (en) Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure (nl)
name	Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure (en) Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure (nl)
title	wds:Q71590582-8BCFB1D7-EBC1-42DB-B1FE-1B15045756A3
title	Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure (en)
page(s)	wds:Q71590582-540B8D1D-0191-47CE-9257-3F41DEC4C603
page(s)	805-808
instance of	wds:Q71590582-9BEF85FF-6003-4CE6-A7C8-5B286D144AF8
instance of	scholarly article
PubMed ID	wds:Q71590582-A607A7C5-DF0D-4535-9812-9B54B5682F7A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8831370
PubMed ID	8831370
published in	wds:Q71590582-54E5387D-7504-46F0-AD76-44477CA76B1A
published in	American Heart Journal
issue	wds:Q71590582-DEA4CC67-6AF7-4657-BA6B-6FDDEA72530E
volume	wds:Q71590582-BCED1982-486F-4996-B08D-95B1BED474B5
issue	4
volume	132
DOI	wds:Q71590582-AA14FC7F-1C58-4108-9323-BE2873D5570D
DOI	http://dx.doi.org/10.1016/S0002-8703(96)90315-4
DOI	10.1016/S0002-8703(96)90315-4
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71590582
is cites work of	Chronic inotropic therapy in end-stage heart failure PDE3 inhibition in dilated cardiomyopathy ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...] 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration Optimizing therapy for complex or refractory heart failure: a management algorithm. Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure. Treatment with B-type natriuretic peptide for chronic decompensated heart failure: insights learned from the follow-up serial infusion of nesiritide (FUSION) trial Maximizing management of patients with decompensated heart failure Dobutamine for Patients with End-Stage Heart Failure in a Hospice Program? Current medical therapy for advanced heart failure Outpatient parenteral inotropic therapy for advanced heart failure Use of Inotropic Agents in Treatment of Systolic Heart Failure Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial Inotropes do not increase mortality in advanced heart failure The dilemma of late-stage heart failure. Rationale for chronic parenteral inotropic support Tolerability of extended duration intravenous milrinone in patients hospitalized for advanced heart failure and the usefulness of uptitration of oral angiotensin-converting enzyme inhibitors Patient Attributes Associated With Better Long-Term Outcomes on Palliative Milrinone Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group Optimising management of patients with advanced heart failure: the importance of preventing progression Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience Parenteral inotropic support for advanced congestive heart failure Synergizing acute care and palliative care to optimise nursing care in end-stage cardiorespiratory disease Positive inotropes in heart failure: a review article Nonpharmacologic treatment of heart failure in the elderly Current medical therapy for advanced heart failure Continuous Intravenous Milrinone Therapy in Pediatric Outpatients Intensive symptom control of opioid-refractory dyspnea in congestive heart failure: Role of milrinone in the palliative care unit Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies Manipulating survival and life quality outcomes in heart failure through disease state management. Preoperative assessment and management of pediatric heart transplantation. Association of preoperative duration of inotropy on prevalence of right ventricular failure following LVAD implantation Refractory heart failure Economic trends and issues related to heart transplantation.
is cites work of	wds:Q33885588-967A8F81-4A0E-49F9-B26F-EF94593AF9B0 wds:Q96305572-87BB3528-0DBC-415B-9D48-D75FB037CDA5

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software